Theralase Technologies Inc. V.TLT

Quiet here

[knoxt]

THERALASE TECHNOLOGIES INC (CA: TLT)

          

Real-time  

Last:

0.335

Change:

0.000

Volume:

69,100

Last Trade:

12:33

  Level ll Quote

Bid			Ask
Price	Total Size	# of Orders	Price	Total Size	# of Orders
$0.335	55500	3	$0.34	1500	1
$0.33	6500	2	$0.345	1000	1
$0.325	45500	5	$0.35	54500	2
$0.32	84000	5	$0.355	57500	2
$0.315	15000	2	$0.36	35500	2
$0.31	19000	4	$0.365	14000	2
$0.30	43500	1	$0.37	147500	5
$0.295	4000	1	$0.38	10500	2
$0.285	58000	2	$0.395	38000	3
$0.28	10000	1	$0.40	258500	8

[99942Apophis]

Yes knoxt it is quiet and that's because we are all waiting for the anticipated results on patients that are pending in both 90 & 180 day results after we see what most are expecting then this volcano will blow and no more quiet. 

[Legit62]

it's the lull before the storm, while we all sit here LONG!!!! waiting

[CancerSlayer]

  This currently dormant volcano will continue to get more active.  In the meantime, many investors simply don't fully grasp the significance of the current evaluable data....coming from an unoptimized cohort (unintended) & optimized cohort (intended).  My so-called inadvertent cohort comparison is clearly signaling to me strong efficacy with correct dosing.   Of

[Legit62]

Having a medical  background, i really liked the way you explained what these trials have accomplished, im a long , big time holder and also have alot of faith in what this company will achieve. soon!!!!! The one thing that still amazes me is the low share volume for a company that will soon show the world it has a cure for cancer.

[CancerSlayer]

  Much appreciated...the low share volume has been a big plus for me : ) What others also may not realize is that there is no reason why a maintenance treatment cannot be used more than once...for those who continue to demonstrate residual, but non-progressing, CIS disease.  There may simply be a subset of patients who need an additional treatment (no more, no less)...all imo

[99942Apophis]

Thanks CancerSlayer you're explanation are well appreciated, thumbs up!

[Mikee3003]

Indeed CS additional TLT maintenace treatments will be investigated, just takes time to run through the trials. I'm going to use Rituximab as an example (one of the top selling oncology drugs with annual sale of approximately $8.5 billion, it is also the world's first onclogy monoclonal antibody therapy). My own personal experience with maintenance treatments has been with Rituxamab for

[CancerSlayer]

  Appreciate your example Mikee & wish you the best in your battle.  You bring up a great point...if all goes well, this current trial will likely be the first of very many.  I am hopeful TLT's ACT can be the WD-40 of cancer treatment...used alone, as an adjuvant/add-on, or as a combo treatment for many cancer indications...not to mention infections.  Good luck &